Cancercare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs
Last Updated on Tuesday, 25 August 2009 03:27 Tuesday, 25 August 2009 03:20
Myeloma Forums - Myeloma Forums

"Door to Door" initiative offers individual grants to patients to help defray transportation costs to and from medical care.
New York, NY, July 20, 2009— CancerCare announced today the launch of the "Door to Door" program for patients with multiple myeloma. CancerCare's program will provide individual grants of up to $600 annually to multiple myeloma patients for covering transportation costs such as gasoline, parking and tolls, and taxi, bus or train fare to and from their medical care.
The program is funded in part by a generous grant from Millennium: The Takeda Oncology Company. CancerCare is a national non-profit organization based in New York City that provides free support services to people affected by cancer.
Multiple myeloma is a cancer of the bone marrow that is diagnosed in approximately 20,000 people annually in the U.S. Advances in the treatment of this cancer have dramatically increased patients' life expectancy (an estimated 60,000 people in the U.S. are now living with multiple myeloma) and consequently lengthened the duration of treatment.
"Because of the nature of their therapies and the disease itself, many multiple myeloma patients may be required to visit their doctors several times a week over many months. Particularly for patients on a fixed income, these travel expenses add up and create a financial burden that may prevent them from keeping up with their health care," noted Diane Blum, executive director of CancerCare. "The Door to Door program will provide much-needed relief to this patient population, and we are grateful for Millennium's support."
Founded in 1944, CancerCare has a long track record of providing financial assistance to people facing cancer; it is a cornerstone of its direct support services to help people cope with the emotional and practical issues of a cancer diagnosis. During fiscal year 2009, CancerCare provided over $4.2 million in grants to more than 24,000 people with cancer to cover treatment-related costs like transportation, child care and medications for side effects.
Last year CancerCare launched a separate foundation to help cancer patients cover the cost of their health insurance co-payments for certain types of treatments. To date, the CancerCare Co-Payment Assistance Foundation has assisted thousands of people undergoing cancer treatments with grants of up to $10,000.
To receive a Door to Door transportation grant, patients must meet certain eligibility criteria and complete an application form. A sample patient application form along with a physician verification form may be viewed online. To apply, call 1-800-813-HOPE (4673).
For more information about multiple myeloma, read CancerCare's free Connect booklet, Advances in the Treatment of Multiple Myeloma.
| < Prev | Next > |
|---|
Users Online
No users online.
Recent Forum Topics
- 03/08/2010 23:13 Mother beginning treatment. (Concerned Son)
- 02/25/2010 17:10 "favorite quotes or sayings" cancer related or not (sunshine)
- 02/25/2010 17:07 "favorite quotes or sayings" cancer related or not (sunshine)
- 02/25/2010 08:55 "favorite quotes or sayings" cancer related or not (ejalt218)
- 02/25/2010 00:21 "favorite quotes or sayings" cancer related or not (sunshine)
- 02/22/2010 18:53 New to the forum (zerofeel)
- 02/22/2010 08:05 New to the forum (AaronTassle)
- 02/21/2010 21:34 Revlimid question (lankheet)
- 02/17/2010 06:57 Thanx (admin)
- 02/16/2010 11:42 Thanx (UFCRuleZ)
- 02/12/2010 11:08 Greetings from Canada! (janiejanjan)
- 02/11/2010 14:08 Second opinions (oldvagirl)
- 02/11/2010 13:43 Greetings from Canada! (oldvagirl)
- 02/10/2010 12:52 Greetings from Canada! (janiejanjan)
- 02/08/2010 23:01 Greetings from Canada! (sunshine)
Tag Cloud
Search Articles
Polls
Polls
Myeloma News
- Facet Biotech Wooed by $722M Acquisition Offer from Abbott (BioWorld)
- Study - Long Term Use of Bisphosphonates Linked To Hip Fractures (InjuryBoard)
- Expert on multiple myeloma to speak at UK Friday (Lexington Herald-Leader)
- Mayo Clinic Receives Unique Philanthropic Gift for Cancer Research (Business Wire via Yahoo! Finance)
- A blood test for breast cancer? Researchers hopeful (CTV.ca)
Medworm
- President Unveils Health Reform Proposal
- New! IMWG Guidelines on Imaging in Diagnosis and Monitoring of MM
- Dr. Greg Mundy, great friend of the IMF and myeloma patients worldwide, has passed away.
- President?s Budget = Funding Increases and Cuts to Blood Cancer Programs
- March is Myeloma Awareness MonthFree Teleconferences!
- March is Myeloma Awareness Month - Free Teleconferences!
- Free Teleconferences for Myeloma Awareness Month!
- Prof. Joan Bladé Recipient of 2010 Kyle Lifetime Achievement Award
Myeloma Beacon
- Regardless Of Prior Therapies, Velcade Is Superior Over Dexamethasone In Relapsed Multiple Myeloma Patients
- Beacon NewsFlashes – March 9, 2010
- Study Documents The Impact Of Age At Diagnosis On Myeloma Patient Survival
- Genetic Risk Factors And Treatment History May Predict Response In Patients With Relapsed/Refractory Myeloma, Study...
- International Effort Updates Results From Multiple Myeloma Stem Cell Transplant Trials
- Thalidomide As Induction And Maintenance Therapy Improves Response Rates In Multiple Myeloma Patients
- The Top Myeloma Research Of 2009
- Achieving Very Good Partial Response Indicates A Good Prognosis For Multiple Myeloma Patients, Study Finds
- Beacon NewsFlashes – February 18, 2010
- Curcumin And Multiple Myeloma: Preclinical And Early Clinical Studies Are Promising; Still Awaiting More Clinical...
Archives by month
Visitors Counter






![]() | Today | 311 |
![]() | Yesterday | 673 |
![]() | This week | 3093 |
![]() | Last week | 731 |
![]() | This month | 3239 |
![]() | Last Month | 19085 |
![]() | All | 96940 |
Your IP: 38.107.191.103
,
Now is: 2010-03-11 11:02








